In hospitalized patients with influenza, oseltamivir or peramivir may reduce hospital length of stay (low-certainty evidence)

Sias J Scherger; Andre C Kalil

doi:10.7326/ANNALS-24-03198-JC

In hospitalized patients with influenza, oseltamivir or peramivir may reduce hospital length of stay (low-certainty evidence)

Ann Intern Med. 2024 Dec;177(12):JC135. doi: 10.7326/ANNALS-24-03198-JC. Epub 2024 Dec 3.

Authors

Sias J Scherger¹, Andre C Kalil¹

Affiliation

¹ University of Nebraska Medical Center, Omaha, Nebraska, USA (S.J.S., A.C.K.).

PMID: 39622060
DOI: 10.7326/ANNALS-24-03198-JC

Abstract

Gao Y, Guyatt G, Uyeki TM, et al. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024;404:753-763. 39181595.

MeSH terms

Acids, Carbocyclic*
Antiviral Agents* / therapeutic use
Cyclopentanes* / therapeutic use
Guanidines / therapeutic use
Hospitalization / statistics & numerical data
Humans
Influenza, Human* / drug therapy
Length of Stay* / statistics & numerical data
Network Meta-Analysis
Oseltamivir* / therapeutic use
Randomized Controlled Trials as Topic
Systematic Reviews as Topic

Substances

Acids, Carbocyclic
Antiviral Agents
Cyclopentanes
Guanidines
Oseltamivir
peramivir